ALMKT:EPA
Mauna Kea Technologies SA
€0.092
arrow_downward
-0.33%(-0.00030) 1D
Oct 27, 10:31:08 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€0.09
High
€0.09
Low
€0.09
Mkt. cap
17.12M
Avg. vol.
453.64K
Volume
92.94K
P/E ratio
0.78
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26M
No. of employees
56
Open
€0.09
High
€0.09
Low
€0.09
Mkt. cap
17.12M
Avg. vol.
453.64K
Volume
92.94K
P/E ratio
0.78
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26M
No. of employees
56
News stories
From web sources and news partners
www.tmgm.com
·
1 hour ago
Dow Jones Futures gain after Wall Street opens week with gains
NAI500
·
16 minutes ago
The S&P 500’s stillness may be the most dangerous move of all
Yahoo Finance
·
34 minutes ago
Amazon Is Underperforming the S&P 500 and Nasdaq-100. Could Oct. 29 Mark a Turning Point?
TradingView
·
3 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA